CoChat

Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis

Open access

The DOI matches its Crossref record; 241 of the 245 references it cites were found in a registry or an index.

Abstract

In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to mesenchymal transition (EMT). The cytoskeleton is an active network of three intracellular filaments: actin cytoskeleton, microtubules, and intermediate filaments. These filaments play a central role in the structural design and cell behavior and are necessary for EMT. During EMT, epithelial cells undergo a cellular transformation as manifested by cell elongation, migration, and invasion, coordinated by actin cytoskeleton reorganization. The actin cytoskeleton is an extremely dynamic structure, controlled by a balance of assembly and disassembly of actin filaments. Actin-binding proteins regulate the process of actin polymerization and depolymerization. Microtubule reorganization also plays an important role in cell migration and polarization. Intermediate filaments are rearranged, switching to a vimentin-rich network, and this protein is used as a marker for a mesenchymal cell. Hence, targeting EMT by regulating the activities of their key components may be a potential solution to metastasis. This review summarizes the research done on the physiological functions of the cytoskeleton, its role in the EMT process, and its effect on multidrug-resistant (MDR) cancer cells-highlight some future perspectives in cancer therapy by targeting cytoskeleton.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers13081882

Cites

241 of 241 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 EMT-MET model for the metastatic cascade: Epithelial cancer cells undergo EMT, which causes them to lose their cell-cell junctions and gain the ability to invade the surrounding tissue parenchyma (Step 1). These EMT-induced cells may then intravasate into the systemic circulation (Step 2) and must survive in the circulation (Step 3) before reaching the target organ site. Upon reaching the target organ site, the cells must then extravasate into the tissue parenchyma (Step 4), following which they may either enter a state of dormancy or form micro metastases. Subsequent development into clinically detectable and potentially life-threatening macro metastases requires MET activation (Step 5).
Figure 1 EMT-MET model for the metastatic cascade: Epithelial cancer cells undergo EMT, which causes them to lose their cell-cell junctions and gain the ability to invade the surrounding tissue parenchyma (Step 1). These EMT-induced cells may then intravasate into the systemic circulation (Step 2) and must survive in the circulation (Step 3) before reaching the target organ site. Upon reaching the target organ site, the cells must then extravasate into the tissue parenchyma (Step 4), following which they may either enter a state of dormancy or form micro metastases. Subsequent development into clinically detectable and potentially life-threatening macro metastases requires MET activation (Step 5).CC BY · PubMed Central
Figure 2 Layout of an epithelial-mesenchymal transition (EMT) transition process and forward migration of cells. Epithelial cells are bound together by tight junctions, adherens junctions, and desmosomes. The adherens junctions are cadherin-based and actin filament-associated cell-to-cell junctions that are composed of defined protein complexes. Epithelial cells are tightly secured to the basement membrane via highly specialized integrin-mediated attachment structures. Signaling pathways are said to trigger the EMT process—propagated by various EMT-TFs, such as ZEB, SNAIL, and TWIST that curb gene expression (listed in the blue box) related with the epithelial state and induce expression of genes associated with the mesenchymal state (listed in the pink box). Mesenchymal cells contain vimentin-based intermediate filaments and use integrin-containing focal adhesions to attach to the ECM. In contrast to epithelial cells, mesenchymal cell migration presents a leading and trailing edge and an extensively reorganized cytoskeleton. Lamellipodia is formed by polymerization of actin by the WAVE-Arp2/3 nucleation mechanism.
Figure 2 Layout of an epithelial-mesenchymal transition (EMT) transition process and forward migration of cells. Epithelial cells are bound together by tight junctions, adherens junctions, and desmosomes. The adherens junctions are cadherin-based and actin filament-associated cell-to-cell junctions that are composed of defined protein complexes. Epithelial cells are tightly secured to the basement membrane via highly specialized integrin-mediated attachment structures. Signaling pathways are said to trigger the EMT process—propagated by various EMT-TFs, such as ZEB, SNAIL, and TWIST that curb gene expression (listed in the blue box) related with the epithelial state and induce expression of genes associated with the mesenchymal state (listed in the pink box). Mesenchymal cells contain vimentin-based intermediate filaments and use integrin-containing focal adhesions to attach to the ECM. In contrast to epithelial cells, mesenchymal cell migration presents a leading and trailing edge and an extensively reorganized cytoskeleton. Lamellipodia is formed by polymerization of actin by the WAVE-Arp2/3 nucleation mechanism.CC BY · PubMed Central
Figure 3 A schematic diagram illustrating the resistance mechanisms associated with anti-microtubule drugs. These drugs cross the lipid bilayer of the cell membrane and then bind themselves to β-tubulin to alter the microtubule dynamics, causing mitotic arrest and consequent apoptosis. Drugs can be effluxed before reaching the cellular target with the aid of functional drug transport protein. Disruption in the tubulin/microtubule system can avert anti-microtubule drugs from disrupting the microtubules and leading to drug resistance. Before drug binding occurs, signaling and anti-apoptotic factors may also contribute to drug resistance. MF: microfilaments, Mt: microtubules. [212]. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.
Figure 3 A schematic diagram illustrating the resistance mechanisms associated with anti-microtubule drugs. These drugs cross the lipid bilayer of the cell membrane and then bind themselves to β-tubulin to alter the microtubule dynamics, causing mitotic arrest and consequent apoptosis. Drugs can be effluxed before reaching the cellular target with the aid of functional drug transport protein. Disruption in the tubulin/microtubule system can avert anti-microtubule drugs from disrupting the microtubules and leading to drug resistance. Before drug binding occurs, signaling and anti-apoptotic factors may also contribute to drug resistance. MF: microfilaments, Mt: microtubules. [212]. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.CC BY · PubMed Central
Figure 4 A diagram illustrating the mechanism of action of Antibody-Drug Conjugate (ADC) in a cancer cell. (A): High-affinity Antibody binds to the drug, forming ADC, entering the double lipid-membrane layer of the cell to cause cell death. (B): ADC binds to the pro-survival receptor of cancer cells, inhibiting its function, commencing apoptosis. (C): ADC binds to both the membrane-surface antigen of the cancer cell and an effector cell in the immune system, inducing cellular cytotoxicity lysing the cancer cells. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.
Figure 4 A diagram illustrating the mechanism of action of Antibody-Drug Conjugate (ADC) in a cancer cell. (A): High-affinity Antibody binds to the drug, forming ADC, entering the double lipid-membrane layer of the cell to cause cell death. (B): ADC binds to the pro-survival receptor of cancer cells, inhibiting its function, commencing apoptosis. (C): ADC binds to both the membrane-surface antigen of the cancer cell and an effector cell in the immune system, inducing cellular cytotoxicity lysing the cancer cells. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 241 references

Cited by

See all 209

Metadata

Authors
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T.
Affiliations
National University of Singapore (SG)
Corresponding author
  • Kumar, Alan Prem
  • Yap, Celestial T.
Venue
Cancers
Publisher
MDPI AG
Published
2021-04-14
Volume
13
Issue
8
Pages
1882
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3156599094
Cited by
184
References
245
Citations by year
2026: 29 · 2025: 45 · 2024: 34 · 2023: 33 · 2022: 30 · 2021: 12
FWCI
3.30
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Medical Research Council (r-185-000-353-213)
  • Ministry of Education - Singapore (MOE-T2EP30120-0016)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
epithelial-mesenchymal transition, cytoskeleton, actin cytoskeleton, microtubules, intermediate filaments, vimentin, metastasis, cell migration, cell invasion, actin-binding proteins, multidrug resistance, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. https://app.cochat.ai/papers/10.3390/cancers13081882
The paper
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T. (2021). Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. Cancers. https://doi.org/10.3390/cancers13081882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.